USPTO serial 79144432
HEPASAFE
Reviewed by CopyMark Law Group
Reg. 4634923Status 404
- Filing date
- Status date
- Registration date
- Nov 11, 2014
- Examiner
- LEVINE, HOWARD B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HEPASAFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SARA M. DORCHAK
SARA M. DORCHAK COLLARD & ROE, P.C.1077 NORTHERN BLVD.ROSLYN, NY 11576UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations used for the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, unstable angina pectoris, and cystic fibrosis; Veterinary preparations used for the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, and unstable angina pectoris in respect to cats, dogs, rabbits, domestic rodents, horses, cows, pigs, sheeps, and goats; Adhesive medical plasters; Medical dressings; Bandages for dressings; Biological preparations for medical use in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, unstable angina pectoris, and cystic fibrosis; Biological preparations for veterinary purposes in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, and unstable angina pectoris in respect to cats, dogs, rabbits, domestic rodents, horses, cows, pigs, sheeps, and goats; Chemical preparations for pharmaceutical or medical use in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, unstable angina pectoris, and cystic fibrosis; Chemical preparations for veterinary purposes in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, and unstable angina pectoris in respect to cats, dogs, rabbits, domestic rodents, horses, cows, pigs, sheeps, and goats; Blood for medical purposes; Anticoagulants for blood; Blood plasma; Blood purification preparations; Ointments for pharmaceutical purposes in the treatment of superficial thrombophlebitis, superficial bruising, haematoma, haemorrhoids, perianal eczema, pruritus, anal fissure, proctitis, periproctitis; Medical preparations for prophylaxis and therapy of thrombosis | SECTION 71 - CANCELLED | — |
| 042 | Scientific laboratory services in the field of blood and blood disorders; Scientific research in the field of blood and blood disorders; Medical research; Research in the field of pharmacy and/or medicine; Research in the field of chemistry; Performance of chemical analyses; Biological research; Quality control for others; Performance of clinical drug testing, namely, conducting clinical drug trials for others | SECTION 71 - CANCELLED | — |
| 044 | Medical and veterinary services; Pharmacy advice, namely, pharmaceutical advice, in particular providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOIBERICA GmbH
- Other trademarks owned by PHARMA ACTION GmbH
- Other trademarks owned by PHARMA ACTION GmbH
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named HEPASAFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 13, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 17, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 23, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| May 23, 2022 | INPC | INVALIDATION PROCESSED | — |
| Jan 28, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 28, 2021 | C71T | CANCELLED SECTION 71 | — |
| Nov 11, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 22, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 1, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 2, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 10, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 10, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 11, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 11, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 26, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 6, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 6, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 6, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 24, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 23, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 23, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 23, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 23, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 23, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 12, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 12, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 4, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jun 27, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2014 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 1, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 1, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 1, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 29, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 28, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 28, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 28, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 27, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |